Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11607453 Mesothelin binding proteins

Patent 11607453 was granted and assigned to Harpoon Therapeutics on March, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Harpoon Therapeutics
Harpoon Therapeutics
0
Date Filed
January 27, 2020
0
Date of Patent
March 21, 2023
0
Patent Applicant
Harpoon Therapeutics
Harpoon Therapeutics
0
Patent Application Number
16773843
0
Patent Citations
‌
US Patent 10544221 Single chain variable fragment CD3 binding proteins
0
‌
US Patent 10066016 Single chain variable fragment CD3 binding proteins
0
‌
US Patent 10100106 Single domain serum albumin binding protein
0
‌
US Patent 10428120 Serum half-life extension using IgBD
0
‌
US Patent 10543271 Mesothelin binding proteins
0
‌
US Patent 11180563 FLT3 binding proteins and methods of use
Patent Inventor Names
Robert B. Dubridge
0
Bryan D. Lemon
0
Holger Wesche
0
Richard J. Austin
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11607453
0
Patent Primary Examiner
‌
Nelson B Moseley, II
0

Find more entities like US Patent 11607453 Mesothelin binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.